Turing Pharmaceuticals

• ‘Pharma Bro’ Martin Shkreli may sacrifice prized Wu-Tang Clan album to pay off $7.36 million federal bill

  In 2015, Shkreli said he had bought the Wu-Tang Clan's 'Once Upon a Time in Shaolin' when the hip-hop group auctioned the sole copy of the album to the highest bidder.

  World

  Mar 5, 2018
  
• ‘Pharma Bro’ Martin Shkreli should surrender Wu-Tang Clan album: prosecutors

  The government wants to seize Shkreli's $2 million copy of "Once Upon a Time in Shaolin," the only copy of the album ever sold.

  Crime

  Dec 1, 2017
  
• Advertisement
• ‘Pharma Bro’ Martin Shkreli accused at trial of cheating investors

  "Pharma Bro" Martin Shkreli is either a con man who scammed hedge fund investors of millions or a nerdy genius who made them even richer.

  Money

  Jun 28, 2017
• Advertisement
• Reputation of ‘Pharma Bro’ precedes him, affects jury selection in his trial

  Several potential jurors at the federal securities fraud trial of Martin "Pharma Bro" Shkreli were excused on Monday after telling the judge they couldn't be impartial toward him.

  Money

  Jun 26, 2017
• Despite pressure from Congress, US drug prices remain sky high

  Congress's routine of publicly shaming drug company executives over high prices works no better than a placebo: It may make some people feel better, but it doesn't treat the problem.

  Money

  Nov 16, 2016
• Martin Shkreli’s price increase strategy not uncommon for drug distributors

  The strategy takes advantage of a simple fact: If generic drugmakers can't get their hands on the original product, they cannot perform the tests needed to develop a generic version.

  Consumer

  Mar 3, 2016
• Drug exec refuses to testify to Congress, calls them ‘imbeciles’

  Infuriating members of Congress, a smirking Martin Shkreli took the Fifth at a Capitol Hill hearing Thursday when asked about his jacking up of drug prices, then promptly went on Twitter and insulted his questioners as "imbeciles."

  Health

  Feb 3, 2016
• Hated price-hiking pharma exec Martin Shkreli gets House subpoena

  House lawmakers have issued a subpoena to compel former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, to appear at a congressional hearing next Tuesday.

  Money

  Jan 20, 2016
• Advertisement
• Martin Shkreli resigns as Turing CEO after securities fraud arrest

  Martin Shkreli, the pharmaceutical executive arrested Thursday on charges of securities fraud related to a company he previously ran, has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals.

  Consumer

  Dec 18, 2015
• Advertisement
• CEO who raised price of life-saving drug 5,000% arrested on securities fraud

  The drug company CEO who sparked worldwide outrage for raising the price of a life-saving pill by 5,000 per cent has been arrested on securities fraud.

  Consumer

  Dec 17, 2015